Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase

γ-Secretase is a unique intramembrane-cleaving protease complex, which cleaves the Alzheimer′s disease-associated β-amyloid precursor protein (APP) and a number of other type I membrane proteins. Human γ-secretase consists of the catalytic subunit presenilin (PS) (PS1 or PS2), the substrate receptor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2009-02, Vol.48 (6), p.1183-1197
Hauptverfasser: Winkler, Edith, Hobson, Scott, Fukumori, Akio, Dümpelfeld, Birgit, Luebbers, Thomas, Baumann, Karlheinz, Haass, Christian, Hopf, Carsten, Steiner, Harald
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1197
container_issue 6
container_start_page 1183
container_title Biochemistry (Easton)
container_volume 48
creator Winkler, Edith
Hobson, Scott
Fukumori, Akio
Dümpelfeld, Birgit
Luebbers, Thomas
Baumann, Karlheinz
Haass, Christian
Hopf, Carsten
Steiner, Harald
description γ-Secretase is a unique intramembrane-cleaving protease complex, which cleaves the Alzheimer′s disease-associated β-amyloid precursor protein (APP) and a number of other type I membrane proteins. Human γ-secretase consists of the catalytic subunit presenilin (PS) (PS1 or PS2), the substrate receptor nicastrin, APH-1 (APH-1a or APH-1b), and PEN-2. To facilitate in-depth biochemical analysis of γ-secretase, we developed a fast and convenient multistep purification procedure for the endogenous enzyme. The enzyme was purified from HEK293 cells in an active form and had a molecular mass of ∼500 kDa. Purified γ-secretase was capable of producing the major amyloid-β peptide (Aβ) species, such as Aβ40 and Aβ42, from a recombinant APP substrate in physiological ratios. Aβ generation could be modulated by pharmacological γ-secretase modulators. Moreover, the Aβ42/Aβ40 ratio was strongly increased by purified PS1 L166P, an aggressive familial Alzheimer’s disease mutant. Tandem mass spectrometry analysis revealed the consistent coisolation of several proteins with the known γ-secretase core subunits. Among these were the previously described γ-secretase interactors CD147 and TMP21 as well as other known interactors of these. Interestingly, the Niemann-Pick type C1 protein, a cholesterol transporter previously implicated in γ-secretase-mediated processing of APP, was identified as a major copurifying protein. Affinity capture experiments using a biotinylated transition-state analogue inhibitor of γ-secretase showed that these proteins are absent from active γ-secretase complexes. Taken together, we provide an effective procedure for isolating endogenous γ-secretase in considerably high grade, thus aiding further characterization of this pivotal enzyme. In addition, we provide evidence that the copurifying proteins identified are unlikely to be part of the active γ-secretase enzyme.
doi_str_mv 10.1021/bi801204g
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67414617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67414617</sourcerecordid><originalsourceid>FETCH-LOGICAL-a313t-6caa118db503d70ec6294a0196f7690440ada855f679b04c6cc31368a49fd0623</originalsourceid><addsrcrecordid>eNptkEFOwzAQRS0EoqWw4AIoG5CQCIwTx6mXUBVaqYhKwDqaOE6bKomLnSzotbgHZ8JtI9iwGv2ZN18zn5BzCrcUAnqXFkOgAbDFAenTKACfCREdkj4AcD8QHHrkxNqVkwxidkx6VNBIBGHUJ5t5a4q8kNgUur7x5ks0FUpd6oXrld6zztqym2GdeQ-FlktV7WYjx6JslCk2O8LTuTetnXZNbexWjutML1StW-tN2gpr7_vLf1XSqAatOiVHOZZWnXV1QN4fx2-jiT97eZqO7mc-hjRsfC4RKR1maQRhFoOSPBAMgQqex1wAY4AZDqMo57FIgUkupdvjQ2Qiz4AH4YBc7X3XRn-0yjZJVVipyhJr5S5LeMwo4zR24PUelEZba1SerE1RoflMKCTboJPfoB170Zm2aaWyP7JL1gGXewClTVa6NbX78R-jH7trhkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67414617</pqid></control><display><type>article</type><title>Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Winkler, Edith ; Hobson, Scott ; Fukumori, Akio ; Dümpelfeld, Birgit ; Luebbers, Thomas ; Baumann, Karlheinz ; Haass, Christian ; Hopf, Carsten ; Steiner, Harald</creator><creatorcontrib>Winkler, Edith ; Hobson, Scott ; Fukumori, Akio ; Dümpelfeld, Birgit ; Luebbers, Thomas ; Baumann, Karlheinz ; Haass, Christian ; Hopf, Carsten ; Steiner, Harald</creatorcontrib><description>γ-Secretase is a unique intramembrane-cleaving protease complex, which cleaves the Alzheimer′s disease-associated β-amyloid precursor protein (APP) and a number of other type I membrane proteins. Human γ-secretase consists of the catalytic subunit presenilin (PS) (PS1 or PS2), the substrate receptor nicastrin, APH-1 (APH-1a or APH-1b), and PEN-2. To facilitate in-depth biochemical analysis of γ-secretase, we developed a fast and convenient multistep purification procedure for the endogenous enzyme. The enzyme was purified from HEK293 cells in an active form and had a molecular mass of ∼500 kDa. Purified γ-secretase was capable of producing the major amyloid-β peptide (Aβ) species, such as Aβ40 and Aβ42, from a recombinant APP substrate in physiological ratios. Aβ generation could be modulated by pharmacological γ-secretase modulators. Moreover, the Aβ42/Aβ40 ratio was strongly increased by purified PS1 L166P, an aggressive familial Alzheimer’s disease mutant. Tandem mass spectrometry analysis revealed the consistent coisolation of several proteins with the known γ-secretase core subunits. Among these were the previously described γ-secretase interactors CD147 and TMP21 as well as other known interactors of these. Interestingly, the Niemann-Pick type C1 protein, a cholesterol transporter previously implicated in γ-secretase-mediated processing of APP, was identified as a major copurifying protein. Affinity capture experiments using a biotinylated transition-state analogue inhibitor of γ-secretase showed that these proteins are absent from active γ-secretase complexes. Taken together, we provide an effective procedure for isolating endogenous γ-secretase in considerably high grade, thus aiding further characterization of this pivotal enzyme. In addition, we provide evidence that the copurifying proteins identified are unlikely to be part of the active γ-secretase enzyme.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi801204g</identifier><identifier>PMID: 19159235</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors ; Amyloid Precursor Protein Secretases - chemistry ; Amyloid Precursor Protein Secretases - isolation &amp; purification ; Amyloid Precursor Protein Secretases - metabolism ; Biotinylation - drug effects ; Cell Line ; Chromatography, Affinity ; Chromatography, Liquid ; Electrophoresis, Polyacrylamide Gel ; Enzyme Inhibitors - pharmacology ; Humans ; Molecular Weight ; Multiprotein Complexes - metabolism ; Mutant Proteins - metabolism ; Protein Binding - drug effects ; Protein Subunits - metabolism ; Substrate Specificity - drug effects ; Tandem Mass Spectrometry</subject><ispartof>Biochemistry (Easton), 2009-02, Vol.48 (6), p.1183-1197</ispartof><rights>Copyright © 2009 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a313t-6caa118db503d70ec6294a0196f7690440ada855f679b04c6cc31368a49fd0623</citedby><cites>FETCH-LOGICAL-a313t-6caa118db503d70ec6294a0196f7690440ada855f679b04c6cc31368a49fd0623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi801204g$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi801204g$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19159235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winkler, Edith</creatorcontrib><creatorcontrib>Hobson, Scott</creatorcontrib><creatorcontrib>Fukumori, Akio</creatorcontrib><creatorcontrib>Dümpelfeld, Birgit</creatorcontrib><creatorcontrib>Luebbers, Thomas</creatorcontrib><creatorcontrib>Baumann, Karlheinz</creatorcontrib><creatorcontrib>Haass, Christian</creatorcontrib><creatorcontrib>Hopf, Carsten</creatorcontrib><creatorcontrib>Steiner, Harald</creatorcontrib><title>Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>γ-Secretase is a unique intramembrane-cleaving protease complex, which cleaves the Alzheimer′s disease-associated β-amyloid precursor protein (APP) and a number of other type I membrane proteins. Human γ-secretase consists of the catalytic subunit presenilin (PS) (PS1 or PS2), the substrate receptor nicastrin, APH-1 (APH-1a or APH-1b), and PEN-2. To facilitate in-depth biochemical analysis of γ-secretase, we developed a fast and convenient multistep purification procedure for the endogenous enzyme. The enzyme was purified from HEK293 cells in an active form and had a molecular mass of ∼500 kDa. Purified γ-secretase was capable of producing the major amyloid-β peptide (Aβ) species, such as Aβ40 and Aβ42, from a recombinant APP substrate in physiological ratios. Aβ generation could be modulated by pharmacological γ-secretase modulators. Moreover, the Aβ42/Aβ40 ratio was strongly increased by purified PS1 L166P, an aggressive familial Alzheimer’s disease mutant. Tandem mass spectrometry analysis revealed the consistent coisolation of several proteins with the known γ-secretase core subunits. Among these were the previously described γ-secretase interactors CD147 and TMP21 as well as other known interactors of these. Interestingly, the Niemann-Pick type C1 protein, a cholesterol transporter previously implicated in γ-secretase-mediated processing of APP, was identified as a major copurifying protein. Affinity capture experiments using a biotinylated transition-state analogue inhibitor of γ-secretase showed that these proteins are absent from active γ-secretase complexes. Taken together, we provide an effective procedure for isolating endogenous γ-secretase in considerably high grade, thus aiding further characterization of this pivotal enzyme. In addition, we provide evidence that the copurifying proteins identified are unlikely to be part of the active γ-secretase enzyme.</description><subject>Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors</subject><subject>Amyloid Precursor Protein Secretases - chemistry</subject><subject>Amyloid Precursor Protein Secretases - isolation &amp; purification</subject><subject>Amyloid Precursor Protein Secretases - metabolism</subject><subject>Biotinylation - drug effects</subject><subject>Cell Line</subject><subject>Chromatography, Affinity</subject><subject>Chromatography, Liquid</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Molecular Weight</subject><subject>Multiprotein Complexes - metabolism</subject><subject>Mutant Proteins - metabolism</subject><subject>Protein Binding - drug effects</subject><subject>Protein Subunits - metabolism</subject><subject>Substrate Specificity - drug effects</subject><subject>Tandem Mass Spectrometry</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEFOwzAQRS0EoqWw4AIoG5CQCIwTx6mXUBVaqYhKwDqaOE6bKomLnSzotbgHZ8JtI9iwGv2ZN18zn5BzCrcUAnqXFkOgAbDFAenTKACfCREdkj4AcD8QHHrkxNqVkwxidkx6VNBIBGHUJ5t5a4q8kNgUur7x5ks0FUpd6oXrld6zztqym2GdeQ-FlktV7WYjx6JslCk2O8LTuTetnXZNbexWjutML1StW-tN2gpr7_vLf1XSqAatOiVHOZZWnXV1QN4fx2-jiT97eZqO7mc-hjRsfC4RKR1maQRhFoOSPBAMgQqex1wAY4AZDqMo57FIgUkupdvjQ2Qiz4AH4YBc7X3XRn-0yjZJVVipyhJr5S5LeMwo4zR24PUelEZba1SerE1RoflMKCTboJPfoB170Zm2aaWyP7JL1gGXewClTVa6NbX78R-jH7trhkg</recordid><startdate>20090217</startdate><enddate>20090217</enddate><creator>Winkler, Edith</creator><creator>Hobson, Scott</creator><creator>Fukumori, Akio</creator><creator>Dümpelfeld, Birgit</creator><creator>Luebbers, Thomas</creator><creator>Baumann, Karlheinz</creator><creator>Haass, Christian</creator><creator>Hopf, Carsten</creator><creator>Steiner, Harald</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090217</creationdate><title>Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase</title><author>Winkler, Edith ; Hobson, Scott ; Fukumori, Akio ; Dümpelfeld, Birgit ; Luebbers, Thomas ; Baumann, Karlheinz ; Haass, Christian ; Hopf, Carsten ; Steiner, Harald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a313t-6caa118db503d70ec6294a0196f7690440ada855f679b04c6cc31368a49fd0623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors</topic><topic>Amyloid Precursor Protein Secretases - chemistry</topic><topic>Amyloid Precursor Protein Secretases - isolation &amp; purification</topic><topic>Amyloid Precursor Protein Secretases - metabolism</topic><topic>Biotinylation - drug effects</topic><topic>Cell Line</topic><topic>Chromatography, Affinity</topic><topic>Chromatography, Liquid</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Molecular Weight</topic><topic>Multiprotein Complexes - metabolism</topic><topic>Mutant Proteins - metabolism</topic><topic>Protein Binding - drug effects</topic><topic>Protein Subunits - metabolism</topic><topic>Substrate Specificity - drug effects</topic><topic>Tandem Mass Spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winkler, Edith</creatorcontrib><creatorcontrib>Hobson, Scott</creatorcontrib><creatorcontrib>Fukumori, Akio</creatorcontrib><creatorcontrib>Dümpelfeld, Birgit</creatorcontrib><creatorcontrib>Luebbers, Thomas</creatorcontrib><creatorcontrib>Baumann, Karlheinz</creatorcontrib><creatorcontrib>Haass, Christian</creatorcontrib><creatorcontrib>Hopf, Carsten</creatorcontrib><creatorcontrib>Steiner, Harald</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winkler, Edith</au><au>Hobson, Scott</au><au>Fukumori, Akio</au><au>Dümpelfeld, Birgit</au><au>Luebbers, Thomas</au><au>Baumann, Karlheinz</au><au>Haass, Christian</au><au>Hopf, Carsten</au><au>Steiner, Harald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2009-02-17</date><risdate>2009</risdate><volume>48</volume><issue>6</issue><spage>1183</spage><epage>1197</epage><pages>1183-1197</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>γ-Secretase is a unique intramembrane-cleaving protease complex, which cleaves the Alzheimer′s disease-associated β-amyloid precursor protein (APP) and a number of other type I membrane proteins. Human γ-secretase consists of the catalytic subunit presenilin (PS) (PS1 or PS2), the substrate receptor nicastrin, APH-1 (APH-1a or APH-1b), and PEN-2. To facilitate in-depth biochemical analysis of γ-secretase, we developed a fast and convenient multistep purification procedure for the endogenous enzyme. The enzyme was purified from HEK293 cells in an active form and had a molecular mass of ∼500 kDa. Purified γ-secretase was capable of producing the major amyloid-β peptide (Aβ) species, such as Aβ40 and Aβ42, from a recombinant APP substrate in physiological ratios. Aβ generation could be modulated by pharmacological γ-secretase modulators. Moreover, the Aβ42/Aβ40 ratio was strongly increased by purified PS1 L166P, an aggressive familial Alzheimer’s disease mutant. Tandem mass spectrometry analysis revealed the consistent coisolation of several proteins with the known γ-secretase core subunits. Among these were the previously described γ-secretase interactors CD147 and TMP21 as well as other known interactors of these. Interestingly, the Niemann-Pick type C1 protein, a cholesterol transporter previously implicated in γ-secretase-mediated processing of APP, was identified as a major copurifying protein. Affinity capture experiments using a biotinylated transition-state analogue inhibitor of γ-secretase showed that these proteins are absent from active γ-secretase complexes. Taken together, we provide an effective procedure for isolating endogenous γ-secretase in considerably high grade, thus aiding further characterization of this pivotal enzyme. In addition, we provide evidence that the copurifying proteins identified are unlikely to be part of the active γ-secretase enzyme.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>19159235</pmid><doi>10.1021/bi801204g</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2009-02, Vol.48 (6), p.1183-1197
issn 0006-2960
1520-4995
language eng
recordid cdi_proquest_miscellaneous_67414617
source MEDLINE; American Chemical Society Journals
subjects Amyloid Precursor Protein Secretases - antagonists & inhibitors
Amyloid Precursor Protein Secretases - chemistry
Amyloid Precursor Protein Secretases - isolation & purification
Amyloid Precursor Protein Secretases - metabolism
Biotinylation - drug effects
Cell Line
Chromatography, Affinity
Chromatography, Liquid
Electrophoresis, Polyacrylamide Gel
Enzyme Inhibitors - pharmacology
Humans
Molecular Weight
Multiprotein Complexes - metabolism
Mutant Proteins - metabolism
Protein Binding - drug effects
Protein Subunits - metabolism
Substrate Specificity - drug effects
Tandem Mass Spectrometry
title Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A46%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification,%20Pharmacological%20Modulation,%20and%20Biochemical%20Characterization%20of%20Interactors%20of%20Endogenous%20Human%20%CE%B3-Secretase&rft.jtitle=Biochemistry%20(Easton)&rft.au=Winkler,%20Edith&rft.date=2009-02-17&rft.volume=48&rft.issue=6&rft.spage=1183&rft.epage=1197&rft.pages=1183-1197&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi801204g&rft_dat=%3Cproquest_cross%3E67414617%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67414617&rft_id=info:pmid/19159235&rfr_iscdi=true